Kriya Announces $270 Million Series C Financing to Advance Fully Integrated Gene Therapy Engine
REDWOOD CITY, Calif. & RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–Kriya Therapeutics, Inc., a fully integrated gene…
News
AI-Powered Retail Analytics Platform, Intelligence Node, Appoints Senior Executives & Advisory Board Members to Drive US Expansion
SAN FRANCISCO–(BUSINESS WIRE)–Global Retail Intelligence leader Intelligence Node announces several strategic hires to accelerate its…
JetBlue Urges Spirit Shareholders to Protect Their Interests and ‘Vote No’ on Frontier Transaction at Upcoming Spirit Special Meeting
JetBlue’s proposal offers Spirit’s shareholders and other stakeholders more value, more certainty and more opportunity…
MUFG Announces Shift in Expected Closing Date of the Sale of MUFG Union Bank to U.S. Bancorp to Second Half of CY2022
TOKYO & NEW YORK–(BUSINESS WIRE)–On September 21, 2021, MUFG and MUFG Bank, a core banking…
Kasten by Veeam Announces NEW Kasten K10 V5.0 with Enhanced Kubernetes Security, Streamlined CI/CD Pipelines and Ecosystem Advancements
New features and capabilities bolster Kubernetes security across the board, help apply shift-left security to…
With Transatel, NTT Rolls out New 5G IoT Service in the USA to Accelerate Connected Industries Transformation
PARIS–(BUSINESS WIRE)–Transatel – subsidiary of NTT since 2019 – announces the worldwide deployment of a…
MUFG Bank, Ltd. UK Regulatory Announcement: MUFG Announces Shift in Expected Closing Date of the Sale of MUFG Union Bank to U.S. Bancorp to Second Half of CY2022
TOKYO & NEW YORK–(BUSINESS WIRE)– Mitsubishi UFJ Financial Group, Inc. (MUFG) MUFG Bank, Ltd. MUFG…
The Nuvias Group Appointed Sole Distribution Partner for Armis across UK and DACH
Nuvias partners gain access to the entire Armis portfolio, addressing the considerable asset visibility market…
De nouvelles données de l’essai en ouvert PLEO-CMT-FU montrent un bénéfice durable de PXT3003 chez les patients atteints de la maladie de Charcot-Marie-Tooth de type 1A après une durée totale de cinq ans d’essai clinique
De nouvelles données de l’essai en ouvert PLEO-CMT-FU montrent un bénéfice durable de PXT3003 chez…
New Data from the Open-Label PLEO-CMT-FU Trial Shows Sustained Benefit with PXT3003 in Patients with Charcot-Marie-Tooth Disease Type 1A After 5 Years of Total Trial Time
New data from the ongoing Open-Label Phase III Extension Study of PXT3003, the PLEO-CMT-FU trial,…
New Data from the Open-Label PLEO-CMT-FU Trial Shows Sustained Benefit with PXT3003 in Patients with Charcot-Marie-Tooth Disease Type 1A After 5 Years of Total Trial Time
New Data from the Open-Label PLEO-CMT-FU Trial Shows Sustained Benefit with PXT3003 in Patients with…
SOM Biotech signs licensing agreement with the University of Minnesota
SOM Biotech signs licensing agreement with the University of Minnesota Barcelona, Spain, 16 May 2022….
Inventiva secures a €50 million credit facility from the European Investment Bank
This credit facility is intended to support the progress and expansion of Inventiva’s pipeline The…
Immunicum AB: Immunicum Announces Positive Interim Results from ADVANCE II Study in AML Maintenance Treatment
Analysis of primary study endpoint was completed with 7 patients showing a measurable residual disease…
Nicox Announces a New Governance Structure
Press Release Nicox Announces a New Governance Structure New governance structure with a separation of…
Valneva Receives Notice of European Commission’s Intent to Terminate COVID-19 Vaccine Purchase Agreement
Saint-Herblain (France), May 16, 2022 – Valneva SE, a specialty vaccine company, today announced that…
ObsEva to Present at the H.C. Wainwright Global Investment 2022 Conference
GENEVA, Switzerland May 16, 2022 – ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company…
Valneva Receives Emergency Use Authorization from the United Arab Emirates for its Inactivated COVID-19 Vaccine
Saint Herblain (France), May 16, 2022 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a…
Angion Announces Phase 1b Trial of ANG-3070 in Patients with Idiopathic Pulmonary Fibrosis
— The FDA has accepted an IND application supporting clinical development of ANG-3070 in IPF…
Kubecost Expands Open Source Project, Community Involvement, and Enterprise Customers in 1H of 2022
Running across clouds or on-prem, Kubecost provides the spend visibility and allocation necessary to significantly…